Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data (Q31878962)
scientific article
Language:
Current Data About Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data
(P31) (Q13442814)
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(Q815382)

(P304) 370-379
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P478) 134
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P577) Thursday, March 1, 2001
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P921) (Q124407)

(Q181600)
(P887)

(Q815382)
(P887)

(P1433) (Q564416)
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P1476) "Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data" (language: en)
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

(P2093) ACE Inhibitors in Diabetic Nephropathy Trialist Group
(P1545) 1
(P248)
(P698) 11242497
(P813) Tuesday, July 4, 2017

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-134-5-200103060-00009
(P698) 11242497